Scanbase

Scanbase, formerly known as Scanbase, Inc., is an early-stage healthcare diagnostics company with locations in Los Angeles, CA, and San Francisco, CA. The company operates in the healthcare industry, specifically within the diagnostics sub-industry, and participated in Y Combinator’s W23 batch. Scanbase employs a team of six members and focuses on improving clinical performance and decreasing sample collection errors through digital solutions. The company provides a platform for change in digital health diagnostics, offering solutions for app creation, replacing paper-based instructions, and interpreting dried blood spots and lateral flow tests to enhance clinical performance. Scanbase utilizes advanced technologies such as artificial intelligence, machine learning, and computer vision to support a wide range of diagnostic tests, including COVID-19, FLU, RSV, STD, and more. The company also provides an API for converting photos of rapid diagnostic tests into results and enables enterprise algorithm factories. Scanbase serves medical companies by offering easy access to diagnostic test analysis and is active in the healthcare and diagnostics industries across the United States and Canada.